Disease free survival in months of all gastric cancer patients divided per stageVincent, H Heemskerk
The overall survival was significantly different in the vaccinated groups compared to the controls (RR=1.06, 95% CI=1.03–1.09, P = 0.863) (Fig. 5). Moreover, the disease-free survival was reported in five studies assessing 892 participants with 20–60 months of follow-up (Table ...
18.Median progression-free surial after treatment was 14 months.治疗后的无进展生存期的中值为14个月。 相关短句/例句 disease free survival无病生存期 1.Objective To investigate the adverse effect,disease free survivaland overall survival of dose-dense chemotherapy in postoperative breast cancer patients...
ALC absolute lymphocyte count, BMI body mass index, DFS disease-free survival. Full size image Table 3 Multi-variable Cox regression analysis for DFS using the BMI/ALC risk stratification group. Full size table In the subgroup analysis, BMI/ALC was a significant risk factor in both young (≤...
With this aim in mind we made an assessment of 5-year disease-free survival in breast cancer patients. Material and Methods: 403 breast cancer patients attending the radiotherapy-chemotherapy center at Rajaii Hospital, Babolsar were studied with regard to first-time recurrence over a period of 5...
In a retrospective cohort of 146 invasive breast cancer patients, HEVs were found to correlate with disease-free, metastasis-free, and overall survival [8]. In addition to tumour regression, the expression of both naïve T cell and Th1 genes correlated with HEV density in human melanoma, fur...
Negative controls run in parallel consisted of TMA sections, where the primary antibody had been omitted or replaced with the appropriate nonimmune serum. Data and statistical analyses Analysis of disease-free survival of patients with tumours showing different scores of staining for each marker was ...
In conclusion, allogeneic HSCT patients tended to have a lower relapse rate, although this difference was not statistically significant. However the OS and EFS were similar in both groups. Both types of transplants can lead to long-term disease-free survival in approximately 40% patients with ...
Disease-free remission without maintenance therapy has lasted from greater than 2 to greater than 52 months in 34 patients (median follow-up, greater than 11 months). These results are similar to those obtained in patients with advanced, high-grade non-Hodgkin's lymphoma treated with primary ...
disease-free survival Acronyms The amount of time that a person with a disease—usually understood to mean cancer—lives without known recurrence. Disease-free survival is a major clinical parameter used to evaluate the efficacy of a particular therapy, which is usually measured in ‘units’ of ...